logo

Stock Screener

Forex Screener

Crypto Screener

KDLY

Kindly MD, Inc. (KDLY)

$

1.61

-0.29 (-18.01%)


Key metrics

Financial statements



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients by integrating prescription medicine and behavioral health services. The company's stock is identified with the symbol 'KDLY' in the market. It offers specialty outpatient clinical services based on a subscription and fee-for-service model to complement traditional healthcare. The financial data pertains to the fiscal year 2023 where the total costs and expenses for the company are $5,388,818.00 reflecting its overall spending. Kindly MD provides a wide range of evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy. Furthermore, the gross profit ratio is -0.04 reflecting the efficiency of the company's production and sales operations, while the net income ratio is -0.43 indicating the company's profitability margin. Additionally, the company engages in data collection and research, as well as online and email campaign marketing services, and conducts the retail sale of health care products through its clinics and online platform. Formerly known as Utah Therapeutic Health Center, LLC, Kindly MD, Inc. rebranded in March 2022 and has been incorporated since 2019, with its headquarters located in Salt Lake City, Utah. The stock is affordable at $1.61 suitable for budget-conscious investors. With a market capitalization of $11,357,204.00 the company is classified as a small-cap player, indicating its relatively modest size within the financial markets. The stock has an average trading volume of 4,963,068.00 indicating moderate liquidity, which is advantageous for investors considering entry or exit points. As a key player in the Medical - Equipment & Services industry, Kindly MD contributes significantly to the overall market landscape, enhancing its visibility and competitive position. It belongs to the Healthcare sector, driving innovation and growth, and reflecting the dynamic nature of the healthcare landscape in which it operates.

What is Kindly MD, Inc. (KDLY)'s current stock price?

The current stock price of Kindly MD, Inc. (KDLY) is $1.60 as of 2025-04-02. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Kindly MD, Inc. (KDLY) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Kindly MD, Inc. stock to fluctuate between $0.65 (low) and $5.25 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-04-02, Kindly MD, Inc.'s market cap is $11,357,204, based on 7,054,164 outstanding shares.

To buy Kindly MD, Inc. (KDLY) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for KDLY. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $3,768,598 | EPS: -$0.27 | Growth: -37.21%.

Visit https://kindlymd.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $5.25 (2025-02-12) | All-time low: $0.65 (2024-11-27).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

KDLY

accessnewswire.com

2 months ago

KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus

The hospital location positions KindlyMD to expand its core service offerings into Weber County SALT LAKE CITY, UT / ACCESS Newswire / January 22, 2025 / KindlyMD ("KindlyMD" or the "Company") (NASDAQ:KDLY), a leading provider of integrated healthcare services, today announced the opening of a new integrated behavioral health clinic location on the campus of Ogden Regional Medical Center, a MountainStar hospital owned by HCA Healthcare. "We are excited to open our new location on the campus of Ogden Regional Medical Center in Utah," said CEO Tim Pickett.

KDLY

accesswire.com

5 months ago

KindlyMD(R) Announces Third Quarter 2024 Financial Results

Q3 Reimbursements from insurance payors totaled $106,567 an increase of 16.4% sequentially KindlyMD now provides more than 90% in-network insurance coverage in Utah SALT LAKE CITY, UT / ACCESSWIRE / November 13, 2024 / ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services, today announced its financial results for the third quarter ended September 30, 2024. "We are pleased with the progress made during the third quarter to expand our credentialing and increase insurance visits, resulting in a 16.4% growth sequentially.

KDLY

accesswire.com

5 months ago

KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility

KindlyMD now provides more than 90% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it is now contracted with Cigna Healthcare, after receiving additional credentialing. Cigna's innovative approach to behavioral health focuses on integrating mental health services with primary care and ensuring that individuals receive comprehensive support tailored to their unique needs.

KDLY

accesswire.com

7 months ago

KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024

SALT LAKE CITY, UT / ACCESSWIRE / September 12, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has been recognized as one of the winners of the Healthcare AI Impact Award 2024. This award spotlights the most forward-thinking companies in healthcare, driving real improvements in patient care and operational efficiency through the use of artificial intelligence.

KDLY

accesswire.com

7 months ago

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

Ms. Pratt, a seasoned mental health counselor with extensive academic and practical experience, will enhance the Company's Complete Care and Therapy services SALT LAKE CITY, UT / ACCESSWIRE / August 22, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce the appointment of Nancy Pratt, a clinical mental health counselor (CMHC), as Behavioral Health Program Director. Ms. Pratt will bolster the KindlyMD leadership team, driving the Company's Complete Care and Therapy services as a key part of their strategic mission to offer comprehensive, Complete Care programs for patients.

KDLY

accesswire.com

8 months ago

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid, and Blue Cross Blue Shield Reimbursement from insurance payors increased 163.7% sequentially and is expected to increase as a percentage of total revenue going forward Reimbursements from insurance payors totaled $126,325 in first half of 2024 as compared to $0 during the first half of 2023 SALT LAKE CITY, UT / ACCESSWIRE / August 14, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its financial results for the second quarter ended June 30, 2024 and is providing a shareholder update. Tim Pickett, PA-C, KindlyMD Founder and CEO, stated, "During the second quarter we successfully closed on our IPO for gross proceeds of approximately $6 million.

KDLY

accesswire.com

8 months ago

KindlyMD to Present at Upcoming August 2024 Investor Conferences

SALT LAKE CITY, UT / ACCESSWIRE / August 13, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that management is scheduled to participate in the following August 2024 conferences. Sidoti Micro-Cap Virtual Conference Presentation Date and Time: Wednesday, August 14th at 11:30 a.m.

KDLY

accesswire.com

8 months ago

KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, announced today that it has submitted a comment to the U.S. Department of Justice, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act ("CSA"), consistent with the view of the Department of Health and Human Services ("HHS") that cannabis has a currently accepted medical use as well as HHS's views concerning cannabis abuse potential and the level of physical or psychological dependence. For the past 54 years, cannabis has been categorized as a Schedule I controlled substance under the Controlled Substances Act.

KDLY

investorplace.com

9 months ago

3 Cannabis Stocks to Buy at a 52-Week Low in July

With the federal government moving to reschedule cannabis to Schedule III, effectively paving the way for medical cannabis legalization, cannabis stocks are in the spotlight. Cannabis stocks initially spiked on the news but quickly returned to previous levels.

KDLY

investorplace.com

9 months ago

3 IPO Gems Flying Under the Radar (for Now)

Though Reddit (NYSE: RDDT ) may have been the most recent big-name IPO, the initial listings market is still cooking, and undervalued IPO stocks abound. The last undervalued IPO stock I picked at the beginning of June, Nano Nuclear Energy (NASDAQ: NNE ), returned over 300% since I first noticed it, further proving that undervalued IPO stocks are out there if you know where to look.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener